Correlation Between Rigel Pharmaceuticals and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Elevation Oncology, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Elevation Oncology.
Diversification Opportunities for Rigel Pharmaceuticals and Elevation Oncology
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Rigel and Elevation is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Elevation Oncology go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Elevation Oncology
Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 1.93 times more return on investment than Elevation Oncology. However, Rigel Pharmaceuticals is 1.93 times more volatile than Elevation Oncology. It trades about 0.35 of its potential returns per unit of risk. Elevation Oncology is currently generating about 0.18 per unit of risk. If you would invest 1,420 in Rigel Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 1,341 from holding Rigel Pharmaceuticals or generate 94.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Elevation Oncology
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Elevation Oncology |
Rigel Pharmaceuticals and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Elevation Oncology
The main advantage of trading using opposite Rigel Pharmaceuticals and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |